This technology enables production of glycosylated peptides using a new method relying an a photocleavable auxiliary comprising a PEG attachment and a thiol group for native chemical ligation (NCL).
This technology enables production of glycosylated peptides using a new, patented method relying on a two-step procedure involving reversibly conjugating a peptide with a hydrophilic polymer such as PEG and subsequently glycosylating the polymer-conjugated peptide using glycosyltransferases.
Microorganisms from the subsurface carry unique cell surface appendages called: hami. This unique structure is composed of one major, self-assembling Protein species and represent a complex but stable structure. The hami provide cost effective manufacturing in a large scale amount and biodegradable nano tool with versatile applications.
The objective of the present invention to provide methods and means which
allow the production of 2,3-Butanediol (23BD) using non-pathogenic organisms and spent sulfite liquor (SSL) as a substrate.
The non-invasive, acute or short-time preventive allergy treatment will be administered as aerosol spray, eye drops, or encapsulated for oral administration, ideally before exposure to the allergen. A complex of antibodies directed against pollen/food allergens with a cell-surface molecule prevents allergic inflammation by trappi ng the allergens on the
mucosal surface of the respi ratory tract, the eyes, or the gut.
Tue present invention relates to the generation and use of self-standing giant porous hydrophilic nanomembranes (PHNM). Currently available nanomembranes are mainly hydrophobic, which greatly limits their application in biotechnology and life sciences. In contrast, the PHNM is made from hydrophilic polymers and is therefore ideally suited for use inaqueous media.